LockdownV1, Main, Exploration, bibRecord, 000692

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Identifieur interne : 000692 ( Main/Exploration ); précédent : 000691; suivant : 000693

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Auteurs : Anjali Verma [Inde] ; Rajesh Rajput [Inde] ; Surender Verma [Inde] ; Vikas K B. Balania [Inde] ; Babita Jangra [Inde]

Source :

Diabetes & metabolic syndrome [ 1878-0334 ]

RBID : pubmed:32679527

Descripteurs français

KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Betacoronavirus (isolement et purification), Diabète de type 1 (physiopathologie), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Femelle (MeSH), Glycémie (analyse), Humains (MeSH), Hyperglycémie (virologie), Hyperglycémie (épidémiologie), Hypoglycémie (virologie), Hypoglycémie (épidémiologie), Hémoglobine A glycosylée (analyse), Incidence (MeSH), Inde (épidémiologie), Infections à coronavirus (complications), Infections à coronavirus (transmission), Infections à coronavirus (virologie), Jeune adulte (MeSH), Marqueurs biologiques (analyse), Mâle (MeSH), Nourrisson (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (transmission), Pneumopathie virale (virologie), Pronostic (MeSH), Quarantaine (statistiques et données numériques), Études de suivi (MeSH), Études transversales (MeSH).
MESH :
- analyse : Glycémie, Hémoglobine A glycosylée, Marqueurs biologiques.
- isolement et purification : Betacoronavirus.
- physiopathologie : Diabète de type 1.
- statistiques et données numériques : Quarantaine.
- virologie : Hyperglycémie, Hypoglycémie, Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Hyperglycémie, Hypoglycémie, Inde, Infections à coronavirus, Pneumopathie virale.
- Adolescent, Adulte, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Incidence, Jeune adulte, Mâle, Nourrisson, Pandémies, Pronostic, Études de suivi, Études transversales.
Wicri :
- geographic : Inde.

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Betacoronavirus (isolation & purification), Biomarkers (analysis), Blood Glucose (analysis), COVID-19 (MeSH), Child (MeSH), Child, Preschool (MeSH), Coronavirus Infections (complications), Coronavirus Infections (transmission), Coronavirus Infections (virology), Cross-Sectional Studies (MeSH), Diabetes Mellitus, Type 1 (physiopathology), Female (MeSH), Follow-Up Studies (MeSH), Glycated Hemoglobin A (analysis), Humans (MeSH), Hyperglycemia (epidemiology), Hyperglycemia (virology), Hypoglycemia (epidemiology), Hypoglycemia (virology), Incidence (MeSH), India (epidemiology), Infant (MeSH), Male (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (transmission), Pneumonia, Viral (virology), Prognosis (MeSH), Quarantine (statistics & numerical data), SARS-CoV-2 (MeSH), Young Adult (MeSH).
MESH :
- chemical , analysis : Biomarkers, Blood Glucose, Glycated Hemoglobin A.
- geographic , epidemiology : India.
- complications : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Hyperglycemia, Hypoglycemia.
- isolation & purification : Betacoronavirus.
- physiopathology : Diabetes Mellitus, Type 1.
- statistics & numerical data : Quarantine.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- virology : Coronavirus Infections, Hyperglycemia, Hypoglycemia, Pneumonia, Viral.
- Adolescent, Adult, COVID-19, Child, Child, Preschool, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Incidence, Infant, Male, Pandemics, Prognosis, SARS-CoV-2, Young Adult.

Abstract

BACKGROUND AND AIMS

COVID 19 is a novel pandemic affecting globally. Although no reliable data suggests that patients of well controlled Type 1 Diabetes Mellitus (T1DM) being at increased risk of becoming severely ill with SARS-CoV2, but lockdown may impact patients with T1DM requiring regular medications and follow up. Hence this study was planned to see the impact of lockdown on glycemic control in patients with T1DM.

METHODS

A cross sectional study was done in T1DM patients in whom a structured questionnaire was administered on follow up within 15 days after lockdown. Data regarding hypoglycemic and hyperglycemic episodes, Diabetic ketoacidosis (DKA), insulin dose missed, regular glucose monitoring, dietary compliance, physical activity, hospitalization during the phase of lockdown was taken. Average blood glucose and HbA1C of lockdown phase was compared with the readings of prelockdown phase.

RESULTS

Out of 52 patients, 36.5% had hyperglycemic and 15.3% had hypoglycemic episodes. Insulin dose was missed in 26.9%, glucose monitoring not done routinely in 36.5% and 17.4% were not diet compliant during lockdown. Average blood glucose during lockdown phase was 276.9 ± 64.7 mg/dl as compared to 212.3 ± 57.9 mg/dl during prelockdown phase. Mean HbA1c value of lockdown (10 ± 1.5%) which was much higher that of pre lockdown (8.8 ± 1.3%) and the difference was statistically significant (p < 0.05).

CONCLUSION

Glycemic control of T1DM patients has worsened mainly due to non availability of insulin/glucostrips during lockdown period. There is a need for preparedness in future so that complications can be minimised.

DOI: 10.1016/j.dsx.2020.07.016
PubMed: 32679527
PubMed Central: PMC7357511

Affiliations:

Inde

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 002021
to stream Main, to step Curation: 002021

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.</title>
<author><name sortKey="Verma, Anjali" sort="Verma, Anjali" uniqKey="Verma A" first="Anjali" last="Verma">Anjali Verma</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, PGIMS, Rohtak, India. Electronic address: dranjali604@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pediatrics, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rajput, Rajesh" sort="Rajput, Rajesh" uniqKey="Rajput R" first="Rajesh" last="Rajput">Rajesh Rajput</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology, PGIMS, Rohtak, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Endocrinology, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Verma, Surender" sort="Verma, Surender" uniqKey="Verma S" first="Surender" last="Verma">Surender Verma</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of General Surgery, PGIMS, Rohtak, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of General Surgery, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Balania, Vikas K B" sort="Balania, Vikas K B" uniqKey="Balania V" first="Vikas K B" last="Balania">Vikas K B. Balania</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology, PGIMS, Rohtak, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Endocrinology, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jangra, Babita" sort="Jangra, Babita" uniqKey="Jangra B" first="Babita" last="Jangra">Babita Jangra</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Community Medicine, BPS, Khanpur, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Community Medicine, BPS, Khanpur</wicri:regionArea>
<wicri:noRegion>Khanpur</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Sep - Oct</date>
<idno type="RBID">pubmed:32679527</idno>
<idno type="pmid">32679527</idno>
<idno type="doi">10.1016/j.dsx.2020.07.016</idno>
<idno type="pmc">PMC7357511</idno>
<idno type="wicri:Area/Main/Corpus">002021</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">002021</idno>
<idno type="wicri:Area/Main/Curation">002021</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">002021</idno>
<idno type="wicri:Area/Main/Exploration">002021</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.</title>
<author><name sortKey="Verma, Anjali" sort="Verma, Anjali" uniqKey="Verma A" first="Anjali" last="Verma">Anjali Verma</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, PGIMS, Rohtak, India. Electronic address: dranjali604@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pediatrics, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rajput, Rajesh" sort="Rajput, Rajesh" uniqKey="Rajput R" first="Rajesh" last="Rajput">Rajesh Rajput</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology, PGIMS, Rohtak, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Endocrinology, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Verma, Surender" sort="Verma, Surender" uniqKey="Verma S" first="Surender" last="Verma">Surender Verma</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of General Surgery, PGIMS, Rohtak, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of General Surgery, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Balania, Vikas K B" sort="Balania, Vikas K B" uniqKey="Balania V" first="Vikas K B" last="Balania">Vikas K B. Balania</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Endocrinology, PGIMS, Rohtak, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Endocrinology, PGIMS, Rohtak</wicri:regionArea>
<wicri:noRegion>Rohtak</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jangra, Babita" sort="Jangra, Babita" uniqKey="Jangra B" first="Babita" last="Jangra">Babita Jangra</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Community Medicine, BPS, Khanpur, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Community Medicine, BPS, Khanpur</wicri:regionArea>
<wicri:noRegion>Khanpur</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Diabetes & metabolic syndrome</title>
<idno type="eISSN">1878-0334</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Betacoronavirus (isolation & purification)</term>
<term>Biomarkers (analysis)</term>
<term>Blood Glucose (analysis)</term>
<term>COVID-19 (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Coronavirus Infections (virology)</term>
<term>Cross-Sectional Studies (MeSH)</term>
<term>Diabetes Mellitus, Type 1 (physiopathology)</term>
<term>Female (MeSH)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Glycated Hemoglobin A (analysis)</term>
<term>Humans (MeSH)</term>
<term>Hyperglycemia (epidemiology)</term>
<term>Hyperglycemia (virology)</term>
<term>Hypoglycemia (epidemiology)</term>
<term>Hypoglycemia (virology)</term>
<term>Incidence (MeSH)</term>
<term>India (epidemiology)</term>
<term>Infant (MeSH)</term>
<term>Male (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Prognosis (MeSH)</term>
<term>Quarantine (statistics & numerical data)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Betacoronavirus (isolement et purification)</term>
<term>Diabète de type 1 (physiopathologie)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Glycémie (analyse)</term>
<term>Humains (MeSH)</term>
<term>Hyperglycémie (virologie)</term>
<term>Hyperglycémie (épidémiologie)</term>
<term>Hypoglycémie (virologie)</term>
<term>Hypoglycémie (épidémiologie)</term>
<term>Hémoglobine A glycosylée (analyse)</term>
<term>Incidence (MeSH)</term>
<term>Inde (épidémiologie)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (transmission)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Jeune adulte (MeSH)</term>
<term>Marqueurs biologiques (analyse)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (transmission)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pronostic (MeSH)</term>
<term>Quarantaine (statistiques et données numériques)</term>
<term>Études de suivi (MeSH)</term>
<term>Études transversales (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Biomarkers</term>
<term>Blood Glucose</term>
<term>Glycated Hemoglobin A</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Glycémie</term>
<term>Hémoglobine A glycosylée</term>
<term>Marqueurs biologiques</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Hyperglycemia</term>
<term>Hypoglycemia</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Diabète de type 1</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Diabetes Mellitus, Type 1</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Quarantine</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Quarantaine</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Hyperglycémie</term>
<term>Hypoglycémie</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Hyperglycemia</term>
<term>Hypoglycemia</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Hyperglycémie</term>
<term>Hypoglycémie</term>
<term>Inde</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>COVID-19</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Male</term>
<term>Pandemics</term>
<term>Prognosis</term>
<term>SARS-CoV-2</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Pandémies</term>
<term>Pronostic</term>
<term>Études de suivi</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND AND AIMS</b>
</p>
<p>COVID 19 is a novel pandemic affecting globally. Although no reliable data suggests that patients of well controlled Type 1 Diabetes Mellitus (T1DM) being at increased risk of becoming severely ill with SARS-CoV2, but lockdown may impact patients with T1DM requiring regular medications and follow up. Hence this study was planned to see the impact of lockdown on glycemic control in patients with T1DM.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>A cross sectional study was done in T1DM patients in whom a structured questionnaire was administered on follow up within 15 days after lockdown. Data regarding hypoglycemic and hyperglycemic episodes, Diabetic ketoacidosis (DKA), insulin dose missed, regular glucose monitoring, dietary compliance, physical activity, hospitalization during the phase of lockdown was taken. Average blood glucose and HbA1C of lockdown phase was compared with the readings of prelockdown phase.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Out of 52 patients, 36.5% had hyperglycemic and 15.3% had hypoglycemic episodes. Insulin dose was missed in 26.9%, glucose monitoring not done routinely in 36.5% and 17.4% were not diet compliant during lockdown. Average blood glucose during lockdown phase was 276.9 ± 64.7 mg/dl as compared to 212.3 ± 57.9 mg/dl during prelockdown phase. Mean HbA1c value of lockdown (10 ± 1.5%) which was much higher that of pre lockdown (8.8 ± 1.3%) and the difference was statistically significant (p < 0.05).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSION</b>
</p>
<p>Glycemic control of T1DM patients has worsened mainly due to non availability of insulin/glucostrips during lockdown period. There is a need for preparedness in future so that complications can be minimised.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32679527</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0334</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>14</Volume>
<Issue>5</Issue>
<PubDate><MedlineDate>2020 Sep - Oct</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Diabetes & metabolic syndrome</Title>
<ISOAbbreviation>Diabetes Metab Syndr</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.</ArticleTitle>
<Pagination><MedlinePgn>1213-1216</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1871-4021(20)30264-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dsx.2020.07.016</ELocationID>
<Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">COVID 19 is a novel pandemic affecting globally. Although no reliable data suggests that patients of well controlled Type 1 Diabetes Mellitus (T1DM) being at increased risk of becoming severely ill with SARS-CoV2, but lockdown may impact patients with T1DM requiring regular medications and follow up. Hence this study was planned to see the impact of lockdown on glycemic control in patients with T1DM.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A cross sectional study was done in T1DM patients in whom a structured questionnaire was administered on follow up within 15 days after lockdown. Data regarding hypoglycemic and hyperglycemic episodes, Diabetic ketoacidosis (DKA), insulin dose missed, regular glucose monitoring, dietary compliance, physical activity, hospitalization during the phase of lockdown was taken. Average blood glucose and HbA1C of lockdown phase was compared with the readings of prelockdown phase.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 52 patients, 36.5% had hyperglycemic and 15.3% had hypoglycemic episodes. Insulin dose was missed in 26.9%, glucose monitoring not done routinely in 36.5% and 17.4% were not diet compliant during lockdown. Average blood glucose during lockdown phase was 276.9 ± 64.7 mg/dl as compared to 212.3 ± 57.9 mg/dl during prelockdown phase. Mean HbA1c value of lockdown (10 ± 1.5%) which was much higher that of pre lockdown (8.8 ± 1.3%) and the difference was statistically significant (p < 0.05).</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Glycemic control of T1DM patients has worsened mainly due to non availability of insulin/glucostrips during lockdown period. There is a need for preparedness in future so that complications can be minimised.</AbstractText>
<CopyrightInformation>Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Verma</LastName>
<ForeName>Anjali</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Pediatrics, PGIMS, Rohtak, India. Electronic address: dranjali604@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rajput</LastName>
<ForeName>Rajesh</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Endocrinology, PGIMS, Rohtak, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Verma</LastName>
<ForeName>Surender</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of General Surgery, PGIMS, Rohtak, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Balania</LastName>
<ForeName>Vikas K B</ForeName>
<Initials>VKB</Initials>
<AffiliationInfo><Affiliation>Department of Endocrinology, PGIMS, Rohtak, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jangra</LastName>
<ForeName>Babita</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Department of Community Medicine, BPS, Khanpur, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D064888">Observational Study</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Diabetes Metab Syndr</MedlineTA>
<NlmUniqueID>101462250</NlmUniqueID>
<ISSNLinking>1871-4021</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C517652">hemoglobin A1c protein, human</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006442" MajorTopicYN="N">Glycated Hemoglobin A</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID 19</Keyword>
<Keyword MajorTopicYN="N">Diabetes mellitus</Keyword>
<Keyword MajorTopicYN="N">Lockdown</Keyword>
</KeywordList>
<CoiStatement>Declaration of competing interest None.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>07</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32679527</ArticleId>
<ArticleId IdType="pii">S1871-4021(20)30264-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.dsx.2020.07.016</ArticleId>
<ArticleId IdType="pmc">PMC7357511</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Disaster Med Public Health Prep. 2009 Oct;3(3):174-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19865042</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2006 Jan;29(1):158-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16373918</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prehosp Disaster Med. 2008 Sep-Oct;23(5):447-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19189614</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Disaster Med Public Health Prep. 2013 Jun;7(3):257-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23103395</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Intern Med. 1998 Feb 9;158(3):274-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9472208</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Metabolism. 2020 Jun;107:154216</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32220612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2020 Aug;43(8):e86-e87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32503838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Care. 2009 Sep;32(9):1632-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19542210</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Ther. 2020 May 11;:1-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32395187</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Diabetes. 2014 May;15(3):175-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23895512</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2004 Sep 17;53(36):837-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15371964</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):319-323</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32298984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Technol Ther. 2020 May 12;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32396400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Chronic Dis. 2005 Nov;2 Spec no:A04</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16263037</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Technol Ther. 2020 Jun;22(6):462-467</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32421355</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prehosp Disaster Med. 2017 Oct;32(5):568-579</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28606191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prehosp Disaster Med. 2008 Mar-Apr;23(2):185-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18557300</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 Sep - Oct;14(5):917-920</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32574982</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychol Med. 1993 Aug;23(3):645-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8234571</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Med Sci. 2008 Aug;336(2):128-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18703906</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Inde</li>
</country>
</list>
<tree><country name="Inde"><noRegion><name sortKey="Verma, Anjali" sort="Verma, Anjali" uniqKey="Verma A" first="Anjali" last="Verma">Anjali Verma</name>
</noRegion>
<name sortKey="Balania, Vikas K B" sort="Balania, Vikas K B" uniqKey="Balania V" first="Vikas K B" last="Balania">Vikas K B. Balania</name>
<name sortKey="Jangra, Babita" sort="Jangra, Babita" uniqKey="Jangra B" first="Babita" last="Jangra">Babita Jangra</name>
<name sortKey="Rajput, Rajesh" sort="Rajput, Rajesh" uniqKey="Rajput R" first="Rajesh" last="Rajput">Rajesh Rajput</name>
<name sortKey="Verma, Surender" sort="Verma, Surender" uniqKey="Verma S" first="Surender" last="Verma">Surender Verma</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000692 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000692 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    LockdownV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32679527
   |texte=   Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32679527" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LockdownV1

This area was generated with Dilib version V0.6.38.
Data generation: Sun Jan 31 08:28:27 2021. Site generation: Sun Jan 31 08:33:49 2021

	Serveur d'exploration sur le confinement (PubMed)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le confinement (PubMed)

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki